Badajos, Baby Boy .
HRN: 29-38-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/30/2026
08/06/2026
IV
48MG
Q24
SEPSIS
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: